BiotechTube
Home/Pipeline/BEX‑202

BEX‑202

COVID‑19 (SARS‑CoV‑2) Infection

PreclinicalActive

Key Facts

Indication
COVID‑19 (SARS‑CoV‑2) Infection
Phase
Preclinical
Status
Active
Company
Beximco Pharmaceuticals

About Beximco Pharmaceuticals

South Korean biotech leveraging AI‑driven small‑molecule drugs for metabolic and infectious diseases.

View full company profile

Therapeutic Areas

Metabolic DiseasesInfectious Diseases